The Saudi Arabia hair loss treatment market size reached USD 43.02 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 87.03 Million by 2033, exhibiting a growth rate (CAGR) of 7.30% during 2025-2033. The market is driven by the increased awareness of hair loss treatment among consumers. Increased disposable incomes and changing aesthetics of self-care are expanding the market, with both males and females seeking treatment for thinning hair and balding. Along with this, improvements in medical technologies and the availability of non-invasive hair loss treatments allow consumers to choose from more cost-friendly and accessible options, thereby augmenting the Saudi Arabia hair loss treatment market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 43.02 Million |
Market Forecast in 2033 | USD 87.03 Million |
Market Growth Rate 2025-2033 | 7.30% |
Growing Consumer Awareness and Changing Perceptions
In Saudi Arabia, growing consumer awareness about hair loss treatment options has led to a shift in societal perceptions. Hair loss was considered a taboo topic in the past, but the visibility of treatment achievements through social media websites and endorsement by celebrities has made it acceptable to more individuals. Also, public figures in the region have played a role in destigmatizing hair loss, fostering a cultural shift toward acceptance and treatment. Furthermore, social media has contributed significantly towards awareness and motivating individuals to pay attention to grooming, including hair loss treatments. According to an industry report, about 35.33 million people have active social media accounts in Saudi Arabia as of 2024. Social media platforms not only help normalize hair loss but also create a space for individuals to share their personal experiences and success stories, encouraging others to seek solutions. As awareness grows, people are more likely to consult specialists and pursue personalized treatments, recognizing hair loss as a common condition that can be addressed. This change of attitude is further enabled by an increase in educational campaigns and the improved availability of information on different hair restoration procedures. Consequently, a more informed consumer base is driving the demand for both surgical and non-surgical hair loss solutions, which is positively impacting Saudi Arabia hair loss treatment market growth.
Expansion of E-Commerce in Hair Loss Treatments
The growth of e-commerce in Saudi Arabia is significantly influencing the market by providing greater accessibility and convenience for consumers. According to an industry report, the e-commerce market in Saudi Arabia is expected to reach USD 708.7 Billion by 2033, exhibiting a growth rate (CAGR) of 12.8% during 2025-2033. This growth underscores the increasing reliance on digital platforms for purchasing products and services, including hair loss treatments. As more consumers turn to e-commerce for their hair care needs, online platforms are becoming a vital channel for both established brands and emerging players in the market. In addition, e-commerce has made over-the-counter products, including minoxidil and finasteride, and professional treatments more accessible, which can be easily bought privately and discreetly from home. Moreover, online consultations with dermatologists and hair professionals are increasing in popularity, enabling one to get customized advice and treatment recommendations without visiting a clinic. The convenience of price comparison shopping, promotional offers, and the option to read customer reviews also play their part in the increased use of online shopping. As internet penetration and consumer confidence in online transactions keep going up, e-commerce expansion will continue to be an important trend in the market, providing both convenience and wider choice for consumers.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on product type, type, route of administration, gender, and distribution channel.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes corticosteroids, antihypertensive, topical immune-modulators, and others.
Type Insights:
A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes non cicatricial (telogen effluvium, androgenetic alopecia, and alopecia areata), cicatricial, and others.
Route of Administration Insights:
The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral and topical.
Gender Insights:
A detailed breakup and analysis of the market based on the gender have also been provided in the report. This includes male and female.
Distribution Channel Insights:
A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern and Central Region, Western Region, Eastern Region, and Southern Region.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered | Corticosteroids, Antihypertensive, Topical Immune-Modulators, Others |
Types Covered |
|
Route of Administrations Covered | Oral, Topical |
Genders Covered | Male, Female |
Distribution Channels Covered | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
Regions Covered | Northern and Central Region, Western Region, Eastern Region, Southern Region |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: